PBH

Prestige Consumer Healthcare Inc.

59.96 USD

Last updated Dec 6, 01:56 UTC

Yesterday HIGH

$60.87

Yesterday LOW

$58.69

52w HIGH

$68.54

52w LOW

$52.9

EPS

1.07

PE

56.04

Next Earnings

Feb 1, 2024

Overview News Government Trades

Prestige Consumer Healthcare Inc. stock is up 0.47% since 30 days ago. The next earnings date is Feb 1, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 73.68% of the previous 18 December’s closed higher than November.

Prestige Consumer Healthcare Inc. develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies.

Stock Exchange

NYSE

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

Tarrytown, United States Of America

Website

prestigebrands.com

Benzinga Newsdesk

Fri Feb 17, 2023

Oppenheimer Maintains Outperform on Prestige Consumer, Lowers Price Target to $71

Oppenheimer analyst Rupesh Parikh maintains Prestige Consumer (NYSE:PBH) with a Outperform and lowers the price target from $72 to $71.
Benzinga Insights

Fri Feb 3, 2023

Prestige Consumer's Return On Capital Employed Insights
Benzinga Newsdesk

Thu Feb 2, 2023

Prestige Consumer Healthcare Narrows FY23 EPS Outlook To $4.18 ($4.18 - $4.20 Prior) Vs. $4.20 Estimate; Free Cash Flow Outlook Of $220M
Benzinga Newsdesk

Thu Feb 2, 2023

Prestige Consumer Healthcare FY23 Revenue Outlook $1.120B - $1.122B Vs. $1.12B Estimate

"With one quarter to go in fiscal year 2023 we anticipate sales between $1,120 and $1,122 equating to over 3% growth on top of our record fiscal 2022 results. Looking ahead, our proven business strategy, portfolio
Benzinga Newsdesk

Thu Feb 2, 2023

Prestige Consumer Q3 EPS $1.04 Beats $1.01 Estimate, Sales $275.52M Beat $273.72M Estimate

Prestige Consumer (NYSE:PBH) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $1.01 by 2.97 percent. This is a 5.05 percent increase over earnings of $0.99 per share from the
Benzinga Newsdesk

Fri Jan 13, 2023

Oppenheimer Maintains Outperform on Prestige Consumer, Raises Price Target to $72

Oppenheimer analyst Rupesh Parikh maintains Prestige Consumer (NYSE:PBH) with a Outperform and raises the price target from $63 to $72.
Benzinga Insights

Thu Nov 24, 2022

Looking Into Prestige Consumer's Return On Capital Employed
Benzinga Insights

Fri Nov 18, 2022

Prestige Consumer's Return On Capital Employed Insights
Benzinga Insights

Thu Nov 17, 2022

Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022

Upgrades
Benzinga Newsdesk

Thu Nov 17, 2022

Canaccord Genuity Initiates Coverage On Prestige Consumer with Buy Rating, Announces Price Target of $71

Canaccord Genuity analyst Susan Anderson initiates coverage on Prestige Consumer (NYSE:PBH) with a Buy rating and announces Price Target of $71.